CS logo
small CS logo
ICH Study Center GmbH & Co. KG

Hamburg, Germany
Grindelallee 35, 20146 Hamburg

About ICH Study Center GmbH & Co. KG


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
13
Janssen Sciences Ireland UC
2
NEAT ID Foundation
2
Heidelberg ImmunoTherapeutics GmbH
1
MUC Research GmbH
1
Rigshospitalet, Denmark
1
University of Minnesota
1
Universitätsklinikum Hamburg-Eppendorf
1
ViiV Healthcare
1
Total Rows: 9

Clinical Trials at ICH Study Center GmbH & Co. KG


During the past decade, ICH Study Center GmbH & Co. KG conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years440011114411222222222200Started TrialsCompleted Trails2015201620172018201920200246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Strategic Timing of Antiretroviral Treatment
2009-04-15
2022-07-27
Completed
4,688
New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
2009-05-15
2018-05-01
Completed
47
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2014-09-01
Completed
708
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2015-04-01
Completed
698
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
2010-11-01
2014-10-01
Completed
482
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
2011-09-01
2014-01-01
Terminated
813
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
2011-08-01
2015-05-01
Completed
61

Rows per page:

1–23 of 23

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "ICH Study Center GmbH & Co. KG" #1 sponsor was "Gilead Sciences" with 13 trials, followed by "Janssen Sciences Ireland UC" with 2 trials sponsored, "NEAT ID Foundation" with 2 trials sponsored, "Heidelberg ImmunoTherapeutics GmbH" with 1 trials sponsored and "MUC Research GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ICH Study Center GmbH & Co. KG" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 13Gilead Sciences: 13Janssen Sciences Ireland UC: 2Janssen Sciences Ireland UC: 2NEAT ID Foundation: 2NEAT ID Foundation: 2HeidelbergImmunoTherapeuticsGmbH: 1HeidelbergImmunoTherapeuticsGmbH: 1MUC Research GmbH: 1MUC Research GmbH: 1Rigshospitalet, Denmark: 1Rigshospitalet, Denmark: 1University of Minnesota: 1University of Minnesota: 1UniversitätsklinikumHamburg-Eppendorf: 1UniversitätsklinikumHamburg-Eppendorf: 1ViiV Healthcare: 1ViiV Healthcare: 1

Created with Highcharts 11.1.0Top CollaboratorsGilead Sciences: 2Gilead Sciences: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Pfizer: 2Pfizer: 2ANRS, EmergingInfectious Diseases: 1ANRS, EmergingInfectious Diseases: 1AbbVie: 1AbbVie: 1Abbott: 1Abbott: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Copenhagen HIVProgramme (CHIP) --Copenhagen, Denmark:1Copenhagen HIVProgramme (CHIP) --Copenhagen, Denmark:1German Center forInfection Research: 1German Center forInfection Research: 1German FederalMinistry of Educationand Research: 1German FederalMinistry of Educationand Research: 1

Clinical Trials Conditions at ICH Study Center GmbH & Co. KG


According to Clinical.Site data, the most researched conditions in "ICH Study Center GmbH & Co. KG" are "HIV Infections" (6 trials), "HIV-1 Infection" (6 trials), "HIV" (4 trials), "HIV-1-infection" (3 trials) and "Acquired Immunodeficiency Syndrome" (2 trials). Many other conditions were trialed in "ICH Study Center GmbH & Co. KG" in a lesser frequency.

Clinical Trials Intervention Types at ICH Study Center GmbH & Co. KG


Most popular intervention types in "ICH Study Center GmbH & Co. KG" are "Drug" (20 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "FTC/TDF" (5 trials), "RTV" (4 trials), "ATV" (3 trials), "EFV/FTC/TDF" (3 trials) and "FTC/RPV/TDF" (3 trials). Other intervention names were less common.

Clinical Trials Genders at ICH Study Center GmbH & Co. KG


The vast majority of trials in "ICH Study Center GmbH & Co. KG" are 23 trials for "All" genders.

Clinical Trials Status at ICH Study Center GmbH & Co. KG


Currently, there are NaN active trials in "ICH Study Center GmbH & Co. KG". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in ICH Study Center GmbH & Co. KG, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ICH Study Center GmbH & Co. KG, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 4Phase 2: 4Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 18Completed: 18Active, not recruiting: 2Active, not recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1